-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab reduced the risk of disease progression or death by 44% vs. THP as 1st-line therapy in patients with HER2-positive metastatic breast cancer in DESTINY-Breast09 Phase III trial
02 Jun 2025 12:21 GMT
… Reproductive Potential: Pregnancy testing: Verify pregnancy … HER2-positive metastatic breast cancer
Breast cancer is the second … metastatic breast cancer patients with an inherited BRCA mutation. … negative breast cancer, an aggressive form of breast cancer, …
-
The 2 surprising factors that ‘increase your breast cancer risk’ as Kara Tointon reveals brave mastectomy
29 May 2025 16:04 GMT
… later the ovaries.
BRCA stands for BReast CAncer. It refers to the … lifetime risk of breast cancer.
She added: "Breast cancer is more … be referred for predictive genetic testing.
"There are … tissue which is where breast cancers are more likely to …
-
The truth about MALE breast cancer: As a man, I never knew I could get it... until I discovered these easily missed symptoms everyone must watch out for
29 May 2025 13:07 GMT
… breast cancer unit of the local hospital in Derbyshire to undergo further testing … men with breast cancer have the BRCA2 breast cancer susceptibility …
Both types of BRCA mutations also increase … symptoms of breast cancer
Symptoms of breast cancer to look …
-
Rapid Review Quiz: Ovarian Cancer Screening and Prevention
04 Jun 2025 15:08 GMT
… However, advances in genetic testing and molecular pathology have … and consideration of BRCA and multigene panel testing in females … surveillance. Importantly, such testing is also offered to … male relatives who have had breast cancer, early-onset cancers, …
-
Preventive removal of Ovary and Fallopian Tube Reduces Early Death Risk in BRCA-Positive Breast Cancer Patients: Lancet
23 May 2025 22:18 GMT
… guidelines recommending BSO for BRCA mutation carriers to improve … .
Women diagnosed with breast cancer who carry particular BRCA1 … a prior history of breast cancer remains uncertain.
Ordinarily, … the ‘gold standard’ for testing how well treatments work. …
-
Inside Olivia Munn's Private World with John Mulaney, Healing from Cancer and Why She Almost Quit Acting (Exclusive)
04 Jun 2025 12:24 GMT
… in which she battled breast cancer and welcomed Méi via … and treatments since her breast cancer diagnosis in April 2023, … a fast-moving and aggressive breast cancer influenced by hormones, in … clear mammogram and testing negative for the BRCA cancer gene, …
-
Study Links MUC1-C to Estrogen Receptor Expression and Endocrine Resistance in HR+/HER2– Breast Cancer
21 May 2025 23:09 GMT
… growth, and cell viability testing, assessed treatment effects. Protein … mice.1
The TCGA BRCA dataset revealed that … -drug conjugate treatment. npj Breast Cancer. April 26, 2025. … Cancer stat facts: Female breast cancer subtypes. National Cancer Institute. …
-
Evaluating the Rapidly Changing ADC Landscape in HR+/HER2– Breast Cancer
21 May 2025 14:58 GMT
… ) in triple-negative breast cancer and hormone receptor (HR … similar to triple-negative [breast cancer], are sacituzumab govitecan, T … BRCA on [the Caris blood test], so I’m getting genetic [testing … receptor 2-negative metastatic breast cancer (TROPiCS-02): a …
-
How Underrepresentation in Research Impacts Breast Cancer Care
21 May 2025 08:45 GMT
… breast cancer susceptibility (including the BRCA genes), which are used in genetic testing … genetic and clinical factors affecting breast cancer across diverse populations. We … “Anyone affected by breast cancer can speak to Breast Cancer Now’s expert nurses …
-
Navigating Treatment/Testing Decisions in Metastatic HR+/HER2– Breast Cancer
20 May 2025 20:53 GMT
The treatment landscape for metastatic hormone receptor(HR)–positive, HER2-negative breast cancer continues to evolve, demanding nuanced clinical decision-making. While endocrine therapy remains the cornerstone of initial management, the emergence of …